Adjusted EBITDA was a loss of USD 6.4 million, aReversalfrom a profit of USD 2.7 million in the third quarter of 2025. Cash used inOperating Activitieswas USD 8.8 million, and cash and equivalents ended September at USD 1.0 million, down USD 6.0 million from …
The company develops a bone regeneration product candidate for spinal fusion based on the NELL-1 protein. On July 9, 2026 it announced a private placement of 2,112,677 shares, or pre-funded warrants, at USD 1.42 per unit, each with Series F and Series G warrants. …
Key HighlightsBoxlight (NASDAQ:BOXL) was trading down 7.33% at USD 1.77 in pre-market on Friday, November 13, 2026, and no company announcement dated November 11 to 13 explaining the move was found.The shares closed at USD 2.69 on October 23, 2026 in published data, so …
CDT Equity, formerly Conduit Pharmaceuticals, describes itself as a data-driven biopharmaceutical company that identifies, enhances and monetizes therapeuticAssetsusing AI and solid-form chemistry. Its pipeline includes AZD1656 in Phase II, AZD5658 in Phase I and AZD5904, which completed Phase I. In 2026 it increased its …
The headline net loss of USD 1.7 million was flattered by a noncash USD 3.1 million gain from changes in theFair Valueof financial instruments. The operating loss was USD 4.8 million, and the nine-month net loss was USD 4.4 million, or USD 0.96 per …
Key HighlightsShares were trading down 39.21% at USD 5.10 in pre-market on Friday, November 13, 2026, implying a prior close near USD 8.39 (calculated), after third-quarter results were released on November 12.Candel now plans to submit its prostate cancerBiologicslicense application, the formal request for …
Cenntro (NASDAQ:CENN) announced the 1-for-60 reverse split on April 9, 2026, and published reports said the shares fell more than 30% that day to an all-time low. The split was meant to cure a bid-price deficiency:Nasdaqhad sent a notice on April 25, 2025 and …
The quarter remains loss-making on a GAAP basis. The net loss was USD 161.2 million, or USD 0.67 per share, and USD 625.8 million for nine months, with GAAP gross margin of 20% against core gross margin of 41%. CoreNet Incomewas USD 29.8 million, …
The company said it launched a process to pursue a value-maximizing sale. Published reports sayOptionsinclude selling substantially all assets, selling the Children's Place and Gymboree brands, or winding down, and that court papers list nine proposals for parts or most of the business. Bids …
The company reiterated 2026 revenue of USD 72 million to USD 76 million, implying fourth-quarter revenue of about USD 22.6 million to USD 26.6 million (calculated from nine-month revenue of USD 49.4 million). Gross margin is now expected in the low 70% range, and …